BriefTea
Every story in sixty words
Get the free app no ads · no paywallHealth · 22 May 2026
Unsplash / Louis Reed
With the Ebola outbreak risk now "very high" in DR Congo, a new vaccine for the Bundibugyo species, which has no proven treatment, could soon be ready for trials. Scientists at Oxford University are developing this experimental vaccine, using ChAdOx1 technology adapted from the Covid pandemic. It could be ready for clinical trials within two to three months.
Reported by BBC · How we write briefs
More briefs
HealthMany NHS Trusts Turn Down Palantir's Patient Data Platform TechnologyRussian Suspect in Deadly London Hospitals Hack Held in Germany HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.